Profil
Arthur C.
Louie currently works at Celator Pharmaceuticals, Inc., as Chief Medical Officer.
Dr. Louie also formerly worked at Bristol Myers Squibb Co., as Director-Cancer Research, Human Genome Sciences, Inc., as Vice President-Medical Affairs, XOMA Corp., as Vice President-Clinical Research, Proneuron Biotechnologies, Inc., as Principal, Wellstat Biologics Corp., as Principal, and Chiron Therapeutics, Inc., as Principal.
Dr. Louie received his undergraduate degree from Haverford College and doctorate degree from New York University School of Medicine.
Postes actifs de Arthur C. Louie
| Sociétés | Poste | Début |
|---|---|---|
| CELATOR PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Arthur C. Louie
| Sociétés | Poste | Fin |
|---|---|---|
Chiron Therapeutics, Inc. | Corporate Officer/Principal | - |
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Operates as development and commercialization of biological agents | Corporate Officer/Principal | - |
| XOMA ROYALTY CORPORATION | Directeur Technique/Scientifique/R&D | - |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for nervous disorders | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Arthur C. Louie
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Celator Pharmaceuticals, Inc.
Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
Haverford College
Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for nervous disorders | Health Technology |
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Operates as development and commercialization of biological agents | Health Technology |
Chiron Therapeutics, Inc. | |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















